Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Receivables - Other: 2020-2023

Historic Receivables - Other for GeneDx Holdings (WGS) over the last 2 years, with Jun 2023 value amounting to $2.9 million.

  • GeneDx Holdings' Receivables - Other fell 33.53% to $2.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was $2.9 million, marking a year-over-year decrease of 33.53%. This contributed to the annual value of $1.5 million for FY2022, which is 2677.78% up from last year.
  • Latest data reveals that GeneDx Holdings reported Receivables - Other of $2.9 million as of Q2 2023, which was down 0.00% from $2.9 million recorded in Q1 2023.
  • In the past 5 years, GeneDx Holdings' Receivables - Other registered a high of $4.4 million during Q2 2022, and its lowest value of $54,000 during Q4 2021.
  • Moreover, its 3-year median value for Receivables - Other was $2.2 million (2022), whereas its average is $2.1 million.
  • Per our database at Business Quant, GeneDx Holdings' Receivables - Other tumbled by 97.34% in 2021 and then skyrocketed by 2,677.78% in 2022.
  • Over the past 4 years, GeneDx Holdings' Receivables - Other (Quarterly) stood at $2.0 million in 2020, then crashed by 97.34% to $54,000 in 2021, then surged by 2,677.78% to $1.5 million in 2022, then tumbled by 33.53% to $2.9 million in 2023.
  • Its last three reported values are $2.9 million in Q2 2023, $2.9 million for Q1 2023, and $1.5 million during Q4 2022.